$3.27 $0.09 (2.8%)

10:31 AM EDT on 06/26/19

Depomed Inc Com (NASDAQ:ASRT)

CAPS Rating: 4 out of 5

A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.

Current Price $3.27 Mkt Cap $196.4M
Open $3.19 P/E Ratio 0.00
Prev. Close $3.18 Div. (Yield) $0.00 (0.0%)
Daily Range $3.18 - $3.27 Volume 24,972
52-Wk Range $2.88 - $5.74 Avg. Daily Vol. 20

Caps

How do you think NASDAQ:ASRT will perform against the market?

Add Stock to CAPS Watchlist

All Players

252 Outperform
15 Underperform
 

All-Star Players

27 Outperform
2 Underperform
 

Wall Street

9 Outperform
1 Underperform
 

Top NASDAQ:ASRT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zarrpac (< 20)
Submitted June 25, 2017

Value of its products worth more than its current market value. Temporary overhang caused by pricing pressures on pharmaceuticals.

ssbb123 (28.99)
Submitted February 22, 2010

"Cancer risk" can't see this being a good investment for the next few months at least.http://www.forbes.com/2010/02/18/xenoport-glaxosmithkline-depomed-markets-equities-pharmaceuticals.html?partner=yahootix

NASDAQ:ASRT VS S&P 500 (SPY)

Fools bullish on NASDAQ:ASRT are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about ASRT.

Recs

0
Member Avatar NorthSeaAscend (56.53) Submitted: 7/24/2018 11:30:16 PM : Outperform Start Price: $8.18 NASDAQ:ASRT Score: -64.77

volatile.

Recs

1
Member Avatar zarrpac (< 20) Submitted: 6/25/2017 6:59:24 AM : Outperform Start Price: $11.11 NASDAQ:ASRT Score: -90.93

Value of its products worth more than its current market value. Temporary overhang caused by pricing pressures on pharmaceuticals.

Recs

0
Member Avatar cptsintl (29.27) Submitted: 8/11/2015 2:39:39 PM : Outperform Start Price: $19.97 NASDAQ:ASRT Score: -138.56

.

Leaderboard

Find the members with the highest scoring picks in ASRT.

Score Leader

zzlangerhans

zzlangerhans (99.77) Score: +420.75

The FDA approval curse claims yet another victim.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
ZeroDotCom 46.57 10/9/2009 Underperform 5Y $5.80 -45.17% +173.42% +218.60 0 Comment
anticitradeshort 32.34 4/20/2009 Underperform NS $2.14 +48.60% +244.42% +195.82 0 Comment
BuyTheDip 63.63 10/13/2009 Underperform 5Y $3.90 -18.46% +171.52% +189.98 0 Comment
WorldOnFire 27.78 2/2/2011 Underperform 3W $8.31 -61.73% +123.60% +185.34 0 Comment
joebowler210 93.48 10/14/2009 Underperform 3M $3.73 -14.75% +168.19% +182.94 0 Comment
reed127 < 20 6/14/2012 Underperform 1Y $4.99 -36.27% +120.33% +156.60 0 Comment
PDTBiotech 89.17 9/28/2012 Underperform NS $5.86 -45.73% +103.08% +148.81 0 Comment
headyinvestor 72.21 9/26/2012 Underperform 5Y $5.80 -45.17% +103.21% +148.38 0 Comment
Brxcqqq 23.80 6/14/2007 Underperform 1Y $5.11 -37.77% +102.12% +139.89 3 Comments
ssbb123 28.99 2/22/2010 Underperform 3M $2.46 +29.26% +161.72% +132.45 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
trackmizuho < 20 5/9/2016 Outperform NS $16.98 -81.27% +41.84% -123.11 0 Comment
TrackJimCramer 86.19 4/18/2016 Outperform 3W $16.46 -80.68% +39.35% -120.03 0 Comment
TrackJimCramer 86.19 12/1/2015 Underperform 3W $19.00 -13.37% -0.68% +12.68 4/18/2016 @ $16.46 0 Comment
TrackJGreenblatt 47.50 10/21/2014 Outperform 1Y $14.93 +18.89% +6.07% +12.82 10/21/2015 @ $17.75 1 Comment
TrackWallachBeth 43.09 7/10/2014 Outperform NS $13.34 -76.16% +49.36% -125.52 0 Comment
TrackJanney 85.22 1/21/2014 Outperform NS $12.28 -74.10% +57.87% -131.97 0 Comment
TrackJimCramer 86.19 12/6/2013 Outperform 3W $8.55 +122.22% +16.44% +105.79 12/1/2015 @ $19.00 0 Comment
TrackRothCapital 69.43 6/3/2013 Outperform NS $5.76 -44.79% +77.98% -122.77 0 Comment
TrackPoisedTo < 20 2/19/2013 Underperform 5Y $6.85 -53.58% +91.36% +144.94 0 Comment
TrackJMP 82.64 1/5/2012 Outperform NS $5.48 -41.97% +130.06% -172.03 0 Comment
TrackAurigaUSA 63.17 9/30/2011 Outperform NS $5.48 -41.97% +154.77% -196.74 0 Comment
TrackJGreenblatt 47.50 8/15/2011 Outperform 5Y $5.21 +1.15% +18.65% -17.50 8/20/2012 @ $5.27 1 Comment
TrackCarisandCo 84.75 10/21/2009 Outperform NS $3.47 -8.36% +167.41% -175.76 0 Comment
trackmerriman 68.79 10/5/2009 Outperform NS $5.85 -56.05% +7.29% -63.34 2/18/2010 @ $2.57 0 Comment
TrackZacks < 20 6/25/2009 Outperform 3M $2.82 -2.49% +15.58% -18.07 7/8/2010 @ $2.75 1 Comment
TrackJGreenblatt 47.50 8/18/2008 Outperform 1Y $4.22 -17.06% -24.61% +7.55 8/17/2009 @ $3.50 2 Comments
TrackRothCapital 69.43 6/20/2008 Outperform NS $3.40 +141.76% +1.83% +139.94 5/3/2011 @ $8.22 0 Comment
TrackTWeisel 87.22 3/15/2007 Outperform NS $3.24 +0.62% +122.46% -121.84 0 Comment
TrackMatrix < 20 8/28/2006 Underperform NS $4.26 +43.90% +6.49% -37.40 4/17/2012 @ $6.13 0 Comment

Advertisement